Research ArticleArticles
Identification of a Novel Liver X Receptor Agonist that Regulates the Expression of Key Cholesterol Homeostasis Genes with Distinct Pharmacological Characteristics
Ni Li, Xiao Wang, Yanni Xu, Yuan Lin, Ningyu Zhu, Peng Liu, Duo Lu and Shuyi Si
Molecular Pharmacology April 2017, 91 (4) 264-276; DOI: https://doi.org/10.1124/mol.116.105213
Ni Li
State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences, Beijing, People’s Republic of China (N.L., Y.L., D.L.); and Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People’s Republic of China (N.L., X.W., Y.X., N.Z., P.L., S.S.)
Xiao Wang
State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences, Beijing, People’s Republic of China (N.L., Y.L., D.L.); and Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People’s Republic of China (N.L., X.W., Y.X., N.Z., P.L., S.S.)
Yanni Xu
State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences, Beijing, People’s Republic of China (N.L., Y.L., D.L.); and Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People’s Republic of China (N.L., X.W., Y.X., N.Z., P.L., S.S.)
Yuan Lin
State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences, Beijing, People’s Republic of China (N.L., Y.L., D.L.); and Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People’s Republic of China (N.L., X.W., Y.X., N.Z., P.L., S.S.)
Ningyu Zhu
State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences, Beijing, People’s Republic of China (N.L., Y.L., D.L.); and Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People’s Republic of China (N.L., X.W., Y.X., N.Z., P.L., S.S.)
Peng Liu
State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences, Beijing, People’s Republic of China (N.L., Y.L., D.L.); and Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People’s Republic of China (N.L., X.W., Y.X., N.Z., P.L., S.S.)
Duo Lu
State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences, Beijing, People’s Republic of China (N.L., Y.L., D.L.); and Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People’s Republic of China (N.L., X.W., Y.X., N.Z., P.L., S.S.)
Shuyi Si
State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences, Beijing, People’s Republic of China (N.L., Y.L., D.L.); and Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People’s Republic of China (N.L., X.W., Y.X., N.Z., P.L., S.S.)
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleArticles
Novel LXR Agonist with Distinct Characteristics
Ni Li, Xiao Wang, Yanni Xu, Yuan Lin, Ningyu Zhu, Peng Liu, Duo Lu and Shuyi Si
Molecular Pharmacology April 1, 2017, 91 (4) 264-276; DOI: https://doi.org/10.1124/mol.116.105213
Jump to section
Related Articles
Cited By...
More in this TOC Section
Articles
Similar Articles
Advertisement